SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-12-467226
Filing Date
2012-11-13
Accepted
2012-11-13 15:31:29
Documents
10
Effectiveness Date
2012-11-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d438012ds8.htm S-8 70557
2 EX-5.1 d438012dex51.htm EX-5.1 5144
3 EX-23.1 d438012dex231.htm EX-23.1 1843
4 EX-99.2 d438012dex992.htm EX-99.2 30499
5 EX-99.3 d438012dex993.htm EX-99.3 31098
6 EX-99.4 d438012dex994.htm EX-99.4 27225
7 EX-99.5 d438012dex995.htm EX-99.5 32103
8 EX-99.6 d438012dex996.htm EX-99.6 27838
9 EX-99.7 d438012dex997.htm EX-99.7 27743
10 GRAPHIC g438012g35l52.jpg GRAPHIC 16689
  Complete submission text file 0001193125-12-467226.txt   278240
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-184909 | Film No.: 121198512
SIC: 2836 Biological Products, (No Diagnostic Substances)